Novartis wins FDA approval for new heart drug, but faces uphill sales battle

Bio Pharma Dive

Leqvio, which Novartis acquired for nearly $10 billion two years ago, arrives with high sales expectations. But uptake could be slow as insurers and doctors weigh the drug's safety and cost-effectiveness

Sales manager

Pharma Phorum

Create and disseminate sales support materials. Manage and develop sales team (sales manager role only). Proven experience of working as part of a sales team. Proven work experience working in a sales-based role. The post Sales manager appeared first on.

Sales 83
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

J&J predicts faster coronavirus vaccine sales amid debate over boosters

Bio Pharma Dive

billion in sales from its shot this year, despite concerns over protection against variants and significant manufacturing setbacks The pharmaceutical company expects $2.5

Sales 247

Gilead sales propped up by COVID-19 drug Veklury

Bio Pharma Dive

Sales of the antiviral drug accounted for a quarter of the biotech's product revenue in the fourth quarter, disguising hits to its business elsewhere

Sales 247

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Merck sees up to $7B in coming sales of coronavirus pill

Bio Pharma Dive

But sales could climb even higher if it works as a preventive treatment too Executives based their projections on contracts already in place for the drug, known as molnupiravir.

Sales 254

Esperion lays off nearly half its workforce as heart drug sales disappoint

Bio Pharma Dive

The company hopes a "streamlined" sales force can turn around a drug launch that's failed to meet expectations amid tough competition from rival medicines

Sales 236

Merck, GSK vaccine sales hit by pandemic as competitors' business booms

Bio Pharma Dive

Both companies blamed the impact of COVID-19 on sharp declines in sales of their shingles, pneumonia and HPV shots

Sales 251

Pfizer forecasts $15B sales boost from coronavirus vaccine orders

Bio Pharma Dive

The estimate for 2021 sales, which Pfizer splits with partner BioNTech, would make the vaccine one of the highest-selling medicines in the industry

Sales 193

Sales coaching: preparing for the new reality in pharma

Pharma Phorum

COVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an accelerant for progress in its use of digital technology and prompting a reassessment of how the sales function should work. The industry faces the dawn of a new age in sales coaching.

Sales 82

Biohaven beats expectations with fast sales of migraine drug

Bio Pharma Dive

Second quarter sales of Nurtec ODT, which recently became the first migraine drug cleared for acute and preventive treatment, were nearly twice what analysts on Wall Street had predicted

Sales 164

Vaccine sales driven down by pandemic's effects on doctor visits

Bio Pharma Dive

Pfizer, Sanofi, GSK and Merck each reported lower vaccine sales as stay-at-home orders kept people from their regular vaccinations

Acceleron provides biggest biopharma deal this year, with $11.5B sale to Merck

Bio Pharma Dive

The acquisition is notable for Merck, which is under pressure to diversify its business beyond the cancer drug Keytruda and has typically favored smaller buyouts

Sales 274

Moderna cuts vaccine sales, delivery targets for 2021

Bio Pharma Dive

The biotech now expects to deliver between 700 million and 800 million doses this year, down from a previous forecast of 800 million to 1 billion

Sales 164

Novartis to consider sale or separation of Sandoz business

Bio Pharma Dive

The generic drug unit has struggled in recent years, while Novartis has moved to focus more narrowly on higher-margin branded medicines

Novartis expects sales lift from expanded heart drug approval

Bio Pharma Dive

The Swiss drugmaker's pill Entresto is now cleared in the U.S. for use in patients with stronger hearts, expanding the eligible population by two-thirds

Sales 231

J&J foresees end to not-for-profit sales of coronavirus vaccine

Bio Pharma Dive

The drugmaker plans to switch over to a commercial business model late next year or early in 2023, said Jennifer Taubert, head of J&J's pharma division

Sales 254

Biohaven migraine drug sales again top Wall Street forecasts

Bio Pharma Dive

The neuroscience-focused biotech continues to win market share in a battle with some of the industry's largest companies

Sales 169

How COVID-19 has changed the role of pharma sales reps

Pharma Phorum

The demise of the pharmaceutical sales representative has been greatly exaggerated over the years. The current restrictions on face-to-face meetings have exacerbated the trend of sales reps’ reduced access to healthcare customers.

Sales 94

Storytelling is a secret weapon for increasing service sales and overcoming employee resistance to change

Scienmag

Social & Behavioral Science change employee Increasing Overcoming resistance sales secret Service storytelling weaponWith the increasing digitalization in manufacturing industries, companies start to integrate big data analytics into business processes and sell smart services.

Sales 83

Delta variant keeps Roche diagnostics sales sky high

Pharma Phorum

High demand for COVID-19 diagnostics driven by the delta variant has led to rocketing sales at Roche’s diagnostics division, allowing the company to raise its sales forecast for the year. Diagnostics sales rose 39% to CHF 13.3 Group sales rose 8% to CHF 46.7

Sales 83

Brands can boost their own reputations and sales by praising rivals

Scienmag

Social & Behavioral Science boost Brands praising reputations rivals salesWhether they’re beefing on billboards or sparring on social media, big brands are known for taking jabs at their competitors (see the famous “Get a Mac” ads or “the chicken sandwich wars”).

DarshanTalks: Sales & Marketing Oversight – April 21, 2021

Pharma Marketing Network

The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Sales and Marketing Oversight – April 21, 2021. [link].

Sales 77

The Covid cash cow – a look at the Covid vaccine sales figures

Pharma Phorum

So too are the sales figures. billion in vaccine sales this year. This sales strategy contrasts to AstraZeneca, which pledged to provide its vaccine on a not-for-profit basis until the pandemic ends. billion in covid vaccine sales in 2021.

Sales 108

Spineology Adds Experienced Sales Executives to Sales Leadership Team

BioTech 365

Spineology Adds Experienced Sales Executives to Sales Leadership Team Spineology Adds Experienced Sales Executives to Sales Leadership Team Two New Area Vice Presidents Bring Additional Spine Industry Leadership to Spineology ST.

Sales 52

Tredegar Completes the Sale of Ownership Interest in kaléo

BioTech 365

Tredegar Completes the Sale of Ownership Interest in kaléo Tredegar Completes the Sale of Ownership Interest in kaléo RICHMOND, Va.–(BUSINESS

Sales 52

Biogennix Reports Record Year for Sales in 2021

BioTech 365

Biogennix Reports Record Year for Sales in 2021 Biogennix Reports Record Year for Sales in 2021 IRVINE, Calif.–(BUSINESS –(BUSINESS WIRE)–Irvine-based Biogennix, an advanced osteobiologics company that develops, manufactures, and distributes proprietary bone grafting products used for bone fusion procedures, announced today … Continue reading → Business Wire

Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical

BioTech 365

Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today announced that it has completed the sale of OMIDRIA (phenylephrine and ketorolac intraocular solution) 1.0%/0.3%

Sales 52

Sales targets and bonuses drove Celgene, Teva drug price hikes, lawmakers charge

Bio Pharma Dive

An 18-month investigation by the House Oversight Committee targeted the pricing practices behind the top-selling drugs Revlimid and Copaxone

Sales 262

Safe group announces consolidated annual sales of €4.6M, up 23%

BioTech 365

Safe group announces consolidated annual sales of €4.6M, up 23% Safe group announces consolidated annual sales of €4.6M, up 23% A return to growth in direct sales of Safe Orthopaedics Safe Medical annual sales up 50% Cash position of €0.9M … Continue reading → GlobeNewswire

Sales 40

What comes next: digital transformation in B2B life sciences sales

Pharma Phorum

As the contours of a post-pandemic world begin to take shape, those working B2B sales in the life sciences acknowledge that the industry must adapt to some permanent shifts. Beyond the initial show-and-tell conversation, the daily tasks of sales reps are broad and often time-consuming.

Sales 68

Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 10 million sales milestone payment to Basilea

BioTech 365

Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 10 million sales milestone payment to Basilea Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 10 million sales milestone payment to Basilea Ad hoc announcement pursuant to Art.

Sales 40

How Market Listening Can Help Drive Your Pharma Sales Funnel

Pharma Mirror

The role of pharma sales reps is an incredibly important part of this lifecycle from initial research to point of sale and distribution, with reps connecting the groundbreaking research and technology of pharma companies with healthcare professionals and medical establishments.

Sales 52

Strong Cresemba® (isavuconazole) sales by Astellas in the U.S. trigger CHF 15 million sales milestone payment to Basilea

BioTech 365

Strong Cresemba® (isavuconazole) sales by Astellas in the U.S. trigger CHF 15 million sales milestone payment to Basilea Strong Cresemba® (isavuconazole) sales by Astellas in the U.S. trigger CHF 15 million sales milestone payment to Basilea Ad hoc announcement pursuant … Continue reading → GlobeNewswire

Sales 40

Pfizer’s COVID jab sales swell again, with $36bn forecast for 2021

Pharma Phorum

Rocketing sales of COVID-19 vaccine Comirnaty have allowed Pfizer to raise its full-year forecasts for the shot once again to a whopping $36 billion, more than double its predictions just a few months ago.

Sales 83

Element Appoints Dean Pipher Chief Sales Officer

BioTech 365

Element Appoints Dean Pipher Chief Sales Officer Element Appoints Dean Pipher Chief Sales Officer BURLINGTON, Ontario–(BUSINESS WIRE)–Element Nutritional Sciences Inc.

Sales 52

Labcorp Announces Proposed Sale of Senior Notes

BioTech 365

Labcorp Announces Proposed Sale of Senior Notes Labcorp Announces Proposed Sale of Senior Notes BURLINGTON, N.C.–(BUSINESS

Sales 56

Gilead lifted by fast sales of COVID-19 drug Veklury. Will they last?

Bio Pharma Dive

sales seem likely to slow in the months ahead Veklury, which was fully approved by the FDA last week, earned Gilead nearly $900 million in the third quarter, although U.S.

Sales 126

Newomics Announces Sales Team and New Kits

BioTech 365

Newomics Announces Sales Team and New Kits Newomics Announces Sales Team and New Kits BERKELEY, Calif.–(BUSINESS –(BUSINESS WIRE)–Newomics Inc.,

Sales 52

Moderna COVID-19 jab sales rocket to $4.2 billion in second quarter

Pharma Phorum

billion from sales of just under 200 million doses of its COVID-19 vaccine, taking its tally since approval to around $6 billion from 302 million shots. The post Moderna COVID-19 jab sales rocket to $4.2 News Sales and Marketing coronavirus COVID-19 COVID-19 vaccine Moderna

Sales 87

Bayer grows sales and earnings significantly

The Pharma Data

Group sales rise by 14.3 percent to 2.089 billion euros / Crop Science reports strong increase in sales and earnings / Pharmaceuticals and Consumer Health again post considerable sales growth / Core earnings per share advance by 29.6 percent (Fx & portfolio adj.)

Sales 52

Spaces still available in the 2021 Sales Awards

Pharma Times

There are still available spaces in the 2021 Sales Awards as we enter the last couple of months for entries

Sales 81

AZ’s COVID-19 jab sales top $1.2bn, but come at a loss

Pharma Phorum

billion in sales from its COVID-19 vaccine Vaxzevria in the first half of this year, but making it available at no profit had weighed on its profit margins. The post AZ’s COVID-19 jab sales top $1.2bn, but come at a loss appeared first on.

Sales 83